http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6294457-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-6294457-B2
titleOfInvention Mesalamine pharmaceutical composition comprising multiple dosing elements for reduced delivery variability
priorityDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407932856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425654805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 29.